Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ADMA

Adma Biologics Inc

Sep 20 • 04:00PM ET

19.98

Dollar change +0.24
Percentage change 1.22	%

Healthcare • Biotechnology • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI IWM XBI VXF IWO IBB DWAS SCHA VTWO VHT

Scroll to Statements

Index	RUT	P/E	142.11	EPS (ttm)	0.14	Insider Own	3.39%	Shs Outstand	226.06M	Perf Week	10.45%
Market Cap	4.66B	Forward P/E	30.50	EPS next Y	0.66	Insider Trans	-10.80%	Shs Float	225.18M	Perf Month	12.00%
Income	34.79M	PEG	-	EPS next Q	0.13	Inst Own	77.85%	Short Float	4.22%	Perf Quarter	81.64%
Sales	330.24M	P/S	14.10	EPS this Y	471.15%	Inst Trans	7.24%	Short Ratio	2.38	Perf Half Y	222.78%
Book/sh	0.81	P/B	24.73	EPS next Y	35.75%	ROA	9.67%	Short Interest	9.50M	Perf Year	462.82%
Cash/sh	0.38	P/C	52.78	EPS next 5Y	-	ROE	20.77%	52W Range	3.06 - 19.92	Perf YTD	342.04%
Dividend Est.	-	P/FCF	69.88	EPS past 5Y	38.68%	ROI	10.59%	52W High	0.33%	Beta	0.61
Dividend TTM	-	Quick Ratio	2.80	Sales past 5Y	73.26%	Gross Margin	45.91%	52W Low	552.94%	ATR (14)	0.95
Dividend Ex-Date	-	Current Ratio	6.87	EPS Y/Y TTM	176.31%	Oper. Margin	25.42%	RSI (14)	69.86	Volatility	5.18% 5.02%
Employees	624	Debt/Eq	0.75	Sales Y/Y TTM	58.69%	Profit Margin	10.53%	Recom	1.00	Target Price	19.00
Option/Short	Yes / Yes	LT Debt/Eq	0.74	EPS Q/Q	562.94%	Payout	-	Rel Volume	11.25	Prev Close	19.74
Sales Surprise	24.01%	EPS Surprise	77.25%	Sales Q/Q	78.29%	Earnings	Aug 08 AMC	Avg Volume	4.00M	Price	19.98
SMA20	13.13%	SMA50	28.67%	SMA200	122.37%	Trades		Volume	44,978,350	Change	1.22%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-19-23	Resumed	Raymond James	Strong Buy	$5
Oct-13-22	Initiated	Mizuho	Buy	$5
Nov-11-21	Upgrade	Raymond James	Outperform → Strong Buy	$5
Nov-09-21	Initiated	Cantor Fitzgerald	Overweight	$4.50
Jun-04-19	Initiated	Jefferies	Buy	$8
Apr-15-19	Reiterated	H.C. Wainwright	Buy	$10 → $13
Feb-07-19	Resumed	H.C. Wainwright	Buy	$10
Dec-11-17	Reiterated	Maxim Group	Buy	$13 → $8
Nov-14-17	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-23-17	Upgrade	Maxim Group	Hold → Buy	$13
Aug-01-16	Downgrade	Maxim Group	Buy → Hold
Jul-25-16	Reiterated	Maxim Group	Buy	$24 → $14
May-13-15	Reiterated	Maxim Group	Buy	$18 → $24
Dec-08-14	Initiated	Oppenheimer	Outperform	$20
Dec-01-14	Reiterated	Maxim Group	Buy	$16 → $18

Show Previous Ratings

Today 05:50PM	Adma Biologics (ADMA) Gains As Market Dips: What You Should Know (Zacks)
Sep-17-24 07:00AM	ADMA Biologics Set to Join S&P SmallCap 600 Index (GlobeNewswire)
Sep-10-24 09:35AM	Adma Biologics (ADMA) Recently Broke Out Above the 20-Day Moving Average (Zacks) -5.93%
09:15AM	ADMA Biologics Inc (ADMA) Hit a 52 Week High, Can the Run Continue? (Zacks)
07:00AM	ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference (GlobeNewswire)
06:43PM	Loading…
Sep-06-24 06:43PM	Palantir Technologies, Dell Technologies, and Erie Indemnity Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) +13.04%
Aug-29-24 09:40AM	Is ADMA Biologics (ADMA) Outperforming Other Medical Stocks This Year? (Zacks)
09:30AM	Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Aug-19-24 11:40AM	ADMA Biologics (ADMA) Hits 52-Week High: More Room to Grow? (Zacks)
Aug-14-24 08:59AM	ADMA Biologics Announces Partial Paydown of Revolving Credit Facility (GlobeNewswire)
Aug-13-24 09:30AM	Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet (Zacks)
09:15AM	ADMA Biologics Inc (ADMA) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-12-24 08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Aug-08-24 09:56PM	ADMA Stock Earnings: ADMA Biologics Beats EPS, Beats Revenue for Q2 2024 (InvestorPlace) +6.46% +30.93%
06:10PM	Adma Biologics (ADMA) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
05:04PM	Loading…
05:04PM	Adma Biologics: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-01-24 07:00AM	ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024 (GlobeNewswire)
Jul-31-24 05:45PM	Adma Biologics (ADMA) Rises But Trails Market: What Investors Should Know (Zacks)
Jul-30-24 05:50PM	Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Jul-25-24 08:50AM	Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why (Zacks)
Jul-24-24 05:50PM	Adma Biologics (ADMA) Stock Moves -1.31%: What You Should Know (Zacks)
Jul-22-24 10:31AM	What's in Store for ADMA Biologics (ADMA) in Q2 Earnings? (Zacks)
Jul-18-24 05:50PM	Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors (Zacks)
Jul-13-24 09:00AM	3 Millionaire-Making Stock Picks With Astounding Growth Potential (InvestorPlace)
Jul-11-24 09:43AM	Bull Run Alert: 3 Stocks Set to Soar in the Coming Months (InvestorPlace)
Jul-09-24 09:40AM	Is ADMA Biologics (ADMA) Stock Outpacing Its Medical Peers This Year? (Zacks)
08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jul-08-24 05:50PM	Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
09:05AM	Implied Volatility Surging for ADMA Biologics (ADMA) Stock Options (Zacks)
09:30AM	Loading…
Jun-27-24 09:30AM	Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? (Zacks)
Jun-26-24 05:50PM	Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know (Zacks)
Jun-20-24 05:50PM	Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
Jun-11-24 09:30AM	Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? (Zacks)
May-13-24 09:40AM	Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? (Zacks)
May-10-24 02:26PM	ADMA Biologics, Inc. (NASDAQ:ADMA) Q1 2024 Earnings Call Transcript (Insider Monkey) +27.13%
01:25PM	ADMA Biologics Inc (ADMA) Surpasses Analyst Revenue and Earnings Forecasts in Q1 2024 (GuruFocus.com)
10:57AM	Update: ADMA Biologics Shares Rise After Company Swings to Q1 Earnings, Lifts 2024 Guidance (MT Newswires)
04:06AM	ADMA Biologics Swings to Q1 Earnings, Revenue Rises; Lifts 2024 Guidance (MT Newswires)
May-09-24 06:20PM	Adma Biologics (ADMA) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:17PM	Adma Biologics: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-02-24 05:45PM	Adma Biologics (ADMA) Rises Higher Than Market: Key Facts (Zacks)
07:00AM	ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024 (GlobeNewswire)
Apr-30-24 09:30AM	Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Apr-29-24 11:26AM	What's in Store for ADMA Biologics (ADMA) in Q1 Earnings? (Zacks)
Apr-25-24 05:45PM	Adma Biologics (ADMA) Stock Moves -0.31%: What You Should Know (Zacks)
Apr-24-24 08:50AM	Recent Price Trend in Adma Biologics (ADMA) is Your Friend, Here's Why (Zacks)
Apr-19-24 05:45PM	Adma Biologics (ADMA) Ascends While Market Falls: Some Facts to Note (Zacks)
Apr-17-24 05:50PM	Adma Biologics (ADMA) Registers a Bigger Fall Than the Market: Important Facts to Note (Zacks)
Apr-10-24 05:45PM	Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Apr-09-24 11:07AM	Is it a Good Idea to Invest in ADMA Biologics (ADMA) Stock Now? (Zacks)
Apr-05-24 08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Apr-01-24 05:50PM	Adma Biologics (ADMA) Suffers a Larger Drop Than the General Market: Key Insights (Zacks)
Mar-22-24 05:50PM	Why the Market Dipped But Adma Biologics (ADMA) Gained Today (Zacks)
Mar-20-24 08:50AM	Recent Price Trend in ADMA Biologics (ADMA) is Your Friend, Here's Why (Zacks)
Mar-18-24 09:55AM	Wall Street Analysts Think Adma Biologics (ADMA) Could Surge 33.56%: Read This Before Placing a Bet (Zacks)
09:30AM	Wall Street Analysts See Adma Biologics (ADMA) as a Buy: Should You Invest? (Zacks)
Mar-15-24 05:50PM	Adma Biologics (ADMA) Stock Moves -0.5%: What You Should Know (Zacks)
Mar-11-24 07:00AM	ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV & BIVIGAM (GlobeNewswire)
Mar-05-24 12:00PM	Adma Biologics (ADMA) Is Up 4.94% in One Week: What You Should Know (Zacks)
07:00AM	ADMA Biologics to Participate in the Raymond James Institutional Investor Conference (GlobeNewswire)
Mar-04-24 08:50AM	Adma Biologics (ADMA) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Mar-01-24 09:55AM	Wall Street Analysts Believe Adma Biologics (ADMA) Could Rally 28.36%: Here's is How to Trade (Zacks)
09:30AM	Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? (Zacks)
Feb-29-24 11:06AM	ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2023 Earnings Call Transcript (Insider Monkey)
10:37AM	Q4 2023 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 05:30PM	Adma Biologics: Q4 Earnings Snapshot (Associated Press Finance)
04:42PM	ADMA Biologics Inc Reports Robust Revenue Growth and Positive Adjusted Net Income for FY 2023 (GuruFocus.com)
04:10PM	ADMA Biologics Announces CFO Transition (GlobeNewswire)
04:05PM	ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Feb-22-24 05:45PM	Adma Biologics (ADMA) Gains But Lags Market: What You Should Know (Zacks)
Feb-21-24 05:50PM	Adma Biologics (ADMA) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
04:05PM	ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024 (GlobeNewswire)
07:00AM	ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics (GlobeNewswire)
Feb-15-24 05:45PM	Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider (Zacks)
08:50AM	Here's Why Momentum in Adma Biologics (ADMA) Should Keep going (Zacks)
Feb-07-24 05:45PM	Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors (Zacks)
Feb-06-24 09:30AM	Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? (Zacks)
Feb-05-24 09:55AM	Does Adma Biologics (ADMA) Have the Potential to Rally 31.55% as Wall Street Analysts Expect? (Zacks)
Feb-02-24 05:50PM	Adma Biologics (ADMA) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-30-24 08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jan-19-24 09:55AM	Wall Street Analysts Predict a 27.09% Upside in Adma Biologics (ADMA): Here's What You Should Know (Zacks)
Jan-17-24 09:30AM	Brokers Suggest Investing in Adma Biologics (ADMA): Read This Before Placing a Bet (Zacks)
Jan-10-24 08:50AM	Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable (Zacks)
Jan-08-24 07:00AM	ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update (GlobeNewswire) +9.32%
Jan-05-24 12:00PM	Are You Looking for a Top Momentum Pick? Why Adma Biologics (ADMA) is a Great Choice (Zacks)
Dec-26-23 09:30AM	Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? (Zacks)
Dec-25-23 09:55AM	Should You Buy Adma Biologics (ADMA) After Golden Cross? (Zacks)
Dec-18-23 04:05PM	ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management (GlobeNewswire)
Dec-12-23 07:00AM	ADMA Biologics Announces FDA Approval for BIVIGAM in the Pediatric Patient Setting for Those 2 Years of Age and Older (GlobeNewswire)
Dec-08-23 09:30AM	Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It? (Zacks)
Dec-06-23 09:40AM	Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year? (Zacks)
Nov-22-23 09:30AM	Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Nov-17-23 06:29PM	Why Adma Biologics Stock Crushed the Market on Friday (Motley Fool)
Nov-16-23 07:00AM	ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD (GlobeNewswire)
Nov-10-23 11:05AM	ADMA Biologics, Inc. (NASDAQ:ADMA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:25PM	Why Adma Biologics Was Trouncing the Market Today (Motley Fool) +5.80%
10:04AM	Q3 2023 ADMA Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 04:49PM	Adma Biologics: Q3 Earnings Snapshot (Associated Press Finance)

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Guiheen Lawrence P.	Director	Sep 09 '24	Option Exercise	10.80	9,000	97,200	162,941	Sep 11 09:00 PM
Guiheen Lawrence P.	Director	Sep 09 '24	Sale	18.47	9,000	166,189	153,941	Sep 11 09:00 PM
Guiheen Lawrence P.	Director	Sep 09 '24	Proposed Sale	16.26	9,000	146,340		Sep 09 09:00 PM
Kestenberg-Messina Kaitlin M.	COO and SVP, Compliance	Aug 30 '24	Option Exercise	3.87	24,150	93,526	473,238	Aug 30 09:05 PM
Kestenberg-Messina Kaitlin M.	COO and SVP, Compliance	Aug 30 '24	Sale	16.90	24,150	408,050	449,088	Aug 30 09:05 PM
Grossman Jerrold B	Director	Aug 29 '24	Option Exercise	4.28	136,861	585,871	604,166	Aug 30 09:02 PM
Grossman Jerrold B	Director	Aug 29 '24	Sale	17.27	136,861	2,363,932	467,305	Aug 30 09:02 PM
Kestenberg-Messina Kaitlin M.	Officer	Aug 30 '24	Proposed Sale	17.22	24,150	415,863		Aug 30 09:00 PM
Grossman Jerrold B	Director	Aug 29 '24	Proposed Sale	17.24	136,861	2,359,484		Aug 29 09:26 PM
Grossman Adam S	President and CEO	Aug 26 '24	Option Exercise	6.84	236,889	1,619,466	2,296,615	Aug 27 09:22 PM
Grossman Adam S	President and CEO	Aug 27 '24	Option Exercise	3.30	389,356	1,283,725	2,449,082	Aug 27 09:22 PM
Grossman Adam S	President and CEO	Aug 27 '24	Sale	17.29	389,356	6,732,900	2,059,726	Aug 27 09:22 PM
Grossman Adam S	President and CEO	Aug 26 '24	Sale	17.69	236,889	4,191,088	2,059,726	Aug 27 09:22 PM
KWON YOUNG	Director	Aug 23 '24	Sale	18.26	60,000	1,095,600	241,441	Aug 27 09:00 PM
Grossman Adam S	Officer	Aug 26 '24	Proposed Sale	18.20	626,245	11,397,659		Aug 26 09:28 PM
Grossman Adam S	President,CEO, and Interim CFO	Jun 14 '24	Sale	10.72	100,000	1,071,980	2,081,475	Jun 14 09:00 PM
ELMS STEVE	Director	Mar 19 '24	Sale	6.08	411,829	2,503,920	2,115,671	Mar 19 09:48 PM
ELMS STEVE	Director	Mar 18 '24	Sale	6.01	49,887	299,821	2,527,500	Mar 19 09:48 PM
ELMS STEVE	Director	Mar 14 '24	Sale	6.05	448,276	2,712,070	2,760,395	Mar 15 09:00 PM
ELMS STEVE	Director	Mar 13 '24	Sale	6.21	407,000	2,527,470	3,208,671	Mar 15 09:00 PM
ELMS STEVE	Director	Mar 15 '24	Sale	6.01	183,008	1,099,878	2,577,387	Mar 15 09:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADMA

Adma Biologics Inc

Upgrade your FINVIZ experience